INGESTION OF SMALL AMOUNTS OF 19-NORANDROSTENEDIONE PRODUCES POSITIVE DOPING TEST RESULTS IN SOME INDIVIDUALS – ANOTHER UNFAIR TESTING PRACTICE
Watson, P., Judkins, C., Houghton, E., Russell, C., & Maughan, R. (2009). Urinary nandrolone metabolite detection after ingestion of a nandrolone precursor. Medicine & Science in Sports & Exercise, 41(4), 766-772.
This study quantified the excretion patterns of the diagnostic metabolites, 19-norandrosterone (19-NA), and 19-noretiocholanolone (19-NE) after ingestion of small doses of 19-nor-4-androstene-3,17-dione (19-norandrostenedione). Males (N = 11) and females (N = 9) followed an overnight fast. In the laboratory, an initial urine sample was collected. Ss then ingested 500 mL of water containing 5 g of creatine monohydrate and 1.0, 2.5, or 5.0 ng (micrograms) of 19-norandrostenedione. The volume of each urine void was measured, and an aliquot was taken. Samples were analyzed for the metabolites 19-NA and 19-NE by GCMS.
Baseline urinary 19-NA concentrations were ~2.0 ng/mL. Ingestion of the supplement resulted in peak mean urinary 19-NA concentrations of 0.68 ± 0.36, 1.56 ± 0.86, and 3.89 ± 3.11 ng/mL in the 1.0-, 2.5-, or 5.0-ng trials, respectively. Under current WADA regulations, ingestion of the 1.0-ng dose produced 0 positive doping tests, 5 Ss tested positive in the 2.5-ng trial, and 15 Ss (75%) had urinary 19-NA concentrations exceeding 2 ng/mL after ingesting creatine containing 5.0 ng of the steroid. The recovery of the ingested dose was highly variable between individuals, with values ranging from 11% to 84%.
Implication. Ingestion of trace amounts of 19-norandrostenedione (nandrolone precursor) can result in transient elevations of urinary 19-NA and 19-NE concentrations in some individuals. The addition of as little as 2.5 ng of 19-norandrostenedione to a supplement (0.00005% contamination) appears sufficient to result in a doping violation in some persons. Such a small amount would have no effect on a human's physiology or endocrine system. The different response patterns across individuals shows the test to be unfair because it locates only some individuals who have ingested the exogenous steroid precursor.
Return to Table of Contents for this issue.